Personal Injury Law

Trasylol linked to 22,000 Deaths

By Jamie Sheller

Trasylol, or aprotinin, is a blood clotting drug that is used during open heart surgery. Bayer Pharmaceuticals manufactured this drug beginning in 1993. As early as January 2006, studies were released that reported an increase risk of severe adverse reactions, including kidney failure, heart attack, and stroke in patients treated with this product. One medical researcher opined that 22,000 lives could have been saved if Trasylol had been taken off the market when he first published his study in January 2006. http://www.pharmalot.com/2008/02/bayers-trayslol-raises-risk-of-death-studies/ In November of 2007, Bayer agreed to temporarily suspend the marketing of Trasylol until further review could be completed. http://www.fda.gov/medwatch/safety/2007/safety07.htm#Trasylol
If you or a loved one has been injured by the use of Trasylol, contact Sheller PC to discuss your legal rights.

Full post as published by Philadelphia Personal Injury Lawyer on February 21, 2008 (boomark / email).